AJMC Staff

The label expansion means risdiplam is approved for spinal muscular atrophy for all ages.

The year that full benefits will stop for Medicare and Social Security is now a year later than previously estimated; diagnostic companies are racing to develop tests for monkeypox as cases surge; the rate of firearm suicides increased by 15% in youth aged between ages 10 and 24.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Regeneron will purchase Sanofi’s stake of cemiplimab (Libtayo) for $900 million in addition to royalties and other possible payments; a patient receives a 3D printed ear implant created using her own cells; the FDA accepts Pfizer’s EUA application for its COVID-19 vaccine for children aged younger than 5.

HHS announces Office of Environmental Justice; CDC says Memorial Day weekend COVID-19 cases were up nearly 6 times over last year; World Health Organization says the monkeypox outbreak is unlikely to lead to a pandemic.

Medicare recipients will see a reduction in premium costs in 2023, although the amount has not yet been announced; the FDA is investigating a hepatitis A outbreak potentially linked to organic strawberries sold by FreshKampo and HEB; approximately 20,640 American adults will be diagnosed with esophageal cancer in 2022, data suggest.

Angel Qin, MD, clinical assistant professor of medicine at the University of Michigan, discusses the need for more clinical trials in small cell lung cancer and for more patients to qualify for trials.

The organizations that can take on 2-sided risk are usually bigger and that’s not always better for health care, said Jayson Slotnik, partner, Health Policy Strategies, Inc.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Apar Kishor Ganti, MD, who chairs the Small Cell Lung Cancer Committee of the National Comprehensive Cancer Network, spoke with The American Journal of Managed Care® (AJMC®) about current issues in small cell lung cancer, including the need to include patients in clinical trials who are more representative of those in clinical practice.

The latest mass shooting in a school has sparked a renewed a debate on mental health and gun control in the United States; CVS will stop filling controlled-substance prescriptions ordered by clinicians who work for telehealth companies Cerebral and Done; the FTC launched an inquiry into the ongoing baby formula shortage.

United States birth rate rises from last year but is still lower than pre-pandemic; a drug plant closure in California could affect availability of 5 essential medications; the No Surprises Act prevented 2 million potential surprise bills in first 2 months of 2022, report says.

Medical oncologist Jeffrey S. Weber, MD, PhD, spoke with The American Journal of Managed Care® (AJMC®) about how treatment options have improved for more advanced melanoma cases and the role that genetic mutations play in choosing therapy.

Pfizer announced positive data of its COVID-19 shot regimen for children under 5 years; providers gear up for increased challenges in distributing abortion medication; hypoallergenic baby formula shipments arrive in the United States.

The study from China sought to evaluate clinical factors associated with survival after recurrence following surgery in ICC.

Julio Chavez, MD, MS, of Moffitt Cancer Center, spoke with The American Journal of Managed Care® (AJMC®) about how new approvals will alter decision making in the treatment of diffuse large B-cell lymphoma (DLBCL).

Lawmakers in Oklahoma pass the nation's most restrictive abortion ban; racial disparities in cancer death rates persist; earlier onset of puberty sparks concern among physicians, researchers.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

The first monkeypox case in the United States was confirmed in Massachusetts; identification, measurement, and reduction of specific low-value services could help population health and reduce medical expenditures; President Joe Biden invokes the Defense Production Act to combat formula shortage.

Ryan Haumschild PharmD, MS, MBA, director of Pharmacy Services at Emory Healthcare and Winship Cancer Institute, spoke with AJMC® about health care resource utilization and clinical decision support in the care of patients with small cell lung cancer (SCLC).

New FDA legislation will reauthorize FDA user fee agreements for biosimilars, medical devices, and prescription and generic drugs; 7 cases of monkeypox have been confirmed in the United Kingdom, but its mode of transmission is still under investigation; according to a budget report, lowering the Medicare eligibility age to 60 would increase federal costs by $155 billion in a 5-year period.

The FDA announces it will streamline the review process to make it easier for foreign manufacturers to ship more formula to the US; researchers in Australia find babies with sudden infant death syndrome (SIDS) have low levels of butyrylcholinesterase in their blood; the federal government approves a third round of COVID-19 test kits and the FDA is expected to authorize booster shots for children aged 5 to 11 years.

FDA to make an announcement regarding importation of baby formula; first-line use of nivolumab and ipilimumab vs standard of care chemotherapy fails to meet primary end point of overall survival in phase 3 CheckMate 901 trial; study finds link between antibiotic prescriptions and inflammatory bowel disease diagnosis in older adults.

Yuman Fong, MD, received the 2022 Flance-Karl Award from the American Surgical Association (ASA), and Leslie Bernstein, PhD, received the Margaret L. Kripke Legend Award for Promotion of Women in Cancer Medicine and Cancer Science.

President Joe Biden announces plans to improve baby formula shortages; Massachusetts reaches settlement with veterans who contracted COVID-19 in long-term care facility; a quarter of Medicare beneficiaries were harmed from hospital stays in 2018.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

A Senate vote to protect abortion access nationwide failed; drug overdoses hit a record high in the United States during 2021; the European Union lifted its travel mask recommendation.

Firearm homicide jumped by nearly 35% between 2019 and 2020; nearly 400 million COVID-19 vaccines were destroyed at Emergent BioSolutions’s Baltimore facility; a study found high blood pressure in younger people may be associated with negative cognitive effects later in life.

Michael Shafique, MD, an assistant professor of thoracic oncology at Moffitt Cancer Center, spoke with The American Journal of Managed Care® about efforts to characterize small cell lung cancer (SCLC) into subtypes as well as the process for treatment selection in this disease.

COVID-19–related hospitalizations are up 17% week over week; an estimated 5 to 14 million Americans could lose their Medicaid coverage this year or next year; the CDC is investigating unexplained cases of severe hepatitis in children.